Viking Therapeutics VKTX
$24.77 −$1.07 (-4.14%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.10 +1.33%
Open$25.62
Prev close$25.84
Day range$24.67 – $26.50
Volume3.65M
Market cap$3.16B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts16
Average target$93.53+277.6% vs. price
- Buy 94%
- Hold 6%
Low $34.00Now $24.77Avg $93.53High $125.00
Recent rating changes
The last 20 actions on file set price targets from $34.00 to $125.00, averaging $95.75.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 30 Oct 2026 | CCORF | BUY | $118.00 |
| 30 Oct 2026 | Maxim Group | BUY | $70.00 |
| 29 Oct 2026 | UBS | BUY | $94.00 |
| 29 Oct 2026 | Piper Sandler | BUY | $90.00 |
| 29 Oct 2026 | Maxim Group | BUY | $70.00 |
| 29 Oct 2026 | BTIG | BUY | $125.00 |
| 29 Oct 2026 | Morgan Stanley | BUY | $95.00 |
| 29 Oct 2026 | Stifel | BUY | $95.00 |
| 29 Oct 2026 | B. Riley Securities | BUY | $85.00 |
| 29 Oct 2026 | H.C. Wainwright | BUY | $102.00 |
| 29 Oct 2026 | Oppenheimer | BUY | $120.00 |
| 28 Oct 2026 | Cantor Fitzgerald | BUY | $100.00 |
| 28 Oct 2026 | Goldman Sachs | HOLD | $34.00 |
| 20 Oct 2026 | CCORF | BUY | $106.00 |
| 15 Oct 2026 | UBS | BUY | $94.00 |
| 14 Oct 2026 | CCORF | BUY | $114.00 |
| 14 Oct 2026 | H.C. Wainwright | BUY | $102.00 |
| 7 Oct 2026 | CCORF | BUY | $114.00 |
| 7 Oct 2026 | Truist Financial | BUY | $85.00 |
| 6 Oct 2026 | H.C. Wainwright | BUY | $102.00 |
No comments yet — be the first to weigh in on VKTX.
Sign in to join the discussion.